SLC1A2 and brain disorder: Given the evidence that reduced EAAT2 is associated with brain diseases, it could be hypothesized that MS protects against EAAT2 dysregulation, which may play a role in normal cognition [52,53], although this hypothesis is only speculative and additional studies are needed to better understand the mechanisms by which EAAT2 expression or activity could alter cognitive functions.